Knoll Capital Management »

Cardiol Therapeutics Inc- foreign shares owned by Knoll Capital Management

Quarter-by-quarter ownership of Cardiol Therapeutics Inc- foreign (CRDL) shares owned by Knoll Capital Management from 13F filings

Historical chart of Knoll Capital Management investment in Cardiol Therapeutics Inc- foreign

Tip: Access up to 7 years of quarterly data

All positions including Cardiol Therapeutics Inc- foreign held by Knoll Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cardiol Therapeutics Inc- foreign by Knoll Capital Management

Quarter filed Position value Share count Share price at filing
2024-09-30 $198k 100k 1.98
2024-06-30 $202k 100k 2.02

More positions owned by Knoll Capital Management

Applied Therapeutics (APLT)
Biohaven Pharmaceutical Holding
Aldeyra Therapeutics (ALDX)
Alamos Gold COM CL New (AGI)
Avadel Pharmaceuticals Sponsored Adr
SPDR Gold Trust Gold SHS (GLD)
Entera Bio SHS (ENTX)
Hookipa Pharma Inc equity
Altimmune Com New (ALT)
Verona Pharma Sponsored Ads (VRNA)
Seabridge Gold (SA)
Ocular Therapeutix (OCUL)
Meiragtx Holdings (MGTX)
Agnico (AEM)
Kinross Gold Corp (KGC)

View all positions for Knoll Capital Management

Top funds holding Cardiol Therapeutics Inc- foreign

Tejara Capital
AdvisorShares Investments
MMCAP International Inc. SPC
Lion Street Advisors
Foundations Investment Advisors
We Are One Seven
Knoll Capital Management
Cambridge Investment Research Advisors
Geode Capital Management
Marble Harbor Investment Counsel
Sontag Advisory
Morgan Stanley
Susquehanna International
Group One Trading
Royal Bank of Canada

View all funds holding Cardiol Therapeutics Inc- foreign